All Topics

Thyroid Disease and Pregnancy

Thyroid disorders are among the most common medical conditions affecting pregnant women. Undiagnosed or undertreated thyroid disease can harm both mother and baby — but with proper monitoring and treatment, outcomes are excellent.

Pregnancy places extraordinary demands on the thyroid gland. Thyroid hormone requirements increase by 25–50% during pregnancy to support fetal brain development, placental function, and maternal metabolism. Women with pre-existing thyroid disease — hypothyroidism, hyperthyroidism, Hashimoto's, or Graves' disease — require careful monitoring and dose adjustments throughout pregnancy. Dr. Guttler has managed thyroid disease in pregnancy for over 50 years and emphasizes that early diagnosis and proactive treatment are essential for healthy outcomes.

Patient Story

Jennifer, 31

Jennifer had Hashimoto's thyroiditis and was on levothyroxine when she became pregnant. Her OB told her to 'just keep taking the same dose.' By week 10, her TSH had risen to 8.2 — far above the pregnancy target of under 2.5. She was exhausted, nauseated beyond normal morning sickness, and anxious. Her OB referred her to Dr. Guttler, who increased her levothyroxine dose immediately and rechecked her TSH every four weeks. By week 14 her TSH was 1.4. She delivered a healthy baby girl at term. 'Dr. Guttler told me the thyroid is the baby's brain until it can make its own hormones. That put everything in perspective,' Jennifer said.

Why Thyroid Health Matters in Pregnancy

The fetal thyroid does not begin producing its own hormones until weeks 10–12 of gestation. Before that, the fetus depends entirely on maternal thyroid hormone for brain development, neuronal migration, and myelination. Even mild maternal hypothyroidism during the first trimester is associated with lower IQ scores, developmental delays, and increased risk of miscarriage and preterm birth.

Hypothyroidism in Pregnancy

Overt hypothyroidism (elevated TSH with low free T4) must be treated immediately in pregnancy. Subclinical hypothyroidism (elevated TSH with normal free T4) is also treated in pregnancy, particularly in women with TPO antibodies. The TSH target in pregnancy is trimester-specific: under 2.5 mIU/L in the first trimester, under 3.0 in the second and third. Levothyroxine doses typically need to increase by 25–50% as soon as pregnancy is confirmed.

Hyperthyroidism in Pregnancy

Graves' disease is the most common cause of hyperthyroidism in pregnancy. Uncontrolled hyperthyroidism increases the risk of miscarriage, preterm birth, preeclampsia, and fetal growth restriction. Treatment with propylthiouracil (PTU) is preferred in the first trimester; methimazole is used in the second and third trimesters. Radioactive iodine is absolutely contraindicated in pregnancy. Neonatal thyroid function must be monitored because maternal TRAb antibodies cross the placenta.

Postpartum Thyroiditis

Postpartum thyroiditis affects 5–10% of women in the year after delivery. It typically presents as a transient hyperthyroid phase (weeks 1–4 postpartum) followed by a hypothyroid phase (months 4–8), with most women recovering normal thyroid function by 12 months. Women with TPO antibodies are at highest risk. Postpartum thyroiditis is frequently misdiagnosed as postpartum depression — thyroid function should be checked in any woman with mood changes after delivery.

Thyroid Nodules Discovered in Pregnancy

Thyroid nodules discovered during pregnancy should be evaluated with ultrasound. Fine-needle aspiration biopsy is safe in pregnancy and should be performed for nodules with suspicious features. Most thyroid cancers discovered in pregnancy are papillary thyroid cancers with an indolent course; surgery can often be safely deferred until after delivery. Dr. Guttler individualizes management based on nodule characteristics, gestational age, and patient preference.

Dr. Guttler's Approach to Thyroid and Pregnancy

Dr. Guttler recommends that all women with known thyroid disease have their TSH checked as soon as pregnancy is confirmed and every 4 weeks through the first half of pregnancy. Women planning pregnancy should optimize their TSH to under 2.5 before conception. He works closely with obstetricians and maternal-fetal medicine specialists to ensure seamless, coordinated care throughout pregnancy and the postpartum period.

Copyright © 1999-2026 GoDaddy, LLC. All rights reserved.

Privacy PolicyTerms of UseDisclaimerGoDaddy Privacy

References to any specific company, product or services on this Site are not controlled by GoDaddy.com LLC and do not constitute or imply its association with or endorsement of third party advertisers.